Dimed S.A (PNVL3) Fair Value & Analysis
Healthcare · BR · Market cap R$1.6B
Fair value as of: Jun 24, 2026
Analysis
Dimed S.A (PNVL3) currently trades at R$10.98, while our model-based Fair Value estimate is R$18.40 — implying the stock looks roughly 67.6% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal hygiene and beauty products, cosmetics and dermocosmetics in Brazil. It sells its products through physical stores in retail industry. Dimed S.A. Distribuidora de Medicamentos was founded in 1920 and is headquartered in Eldorado do Sul, Brazil.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Dimed S.A (PNVL3) undervalued?
What is the fair value of PNVL3?
What is the quality score of PNVL3?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.